Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2004 10
2005 5
2006 9
2007 13
2008 16
2009 14
2010 20
2011 18
2012 19
2013 20
2014 28
2015 33
2016 22
2017 21
2018 18
2019 19
2020 18
2021 23
2022 28
2023 11
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Results by year

Filters applied: . Clear all
Page 1
The establishment of a multiple myeloma clinical registry in the Asia-Pacific region: The Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR).
Aoki N, Chen PY, Chen W, Chng WJ, Gan GG, Goh YT, Hou J, Huang J, Kim K, Lee JJ, Lu J, McQuilten ZK, Min CK, Moore E, Oliver L, Waters NA, Wellard C, Wood EM, Yeh SP, Spencer A; APAC MRDR Investigators. Aoki N, et al. Among authors: lee jj. BMC Med Res Methodol. 2024 May 2;24(1):102. doi: 10.1186/s12874-024-02227-0. BMC Med Res Methodol. 2024. PMID: 38698331 Free PMC article.
Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia.
Song GY, Kim HJ, Kim T, Ahn SY, Jung SH, Kim M, Yang DH, Lee JJ, Kim MY, Cheong JW, Jung CW, Jang JH, Kim HJ, Moon JH, Sohn SK, Won JH, Park SK, Kim SH, Choi CK, Kim HJ, Ahn JS, Kim DDH. Song GY, et al. Among authors: lee jj. Sci Rep. 2024 Apr 12;14(1):8517. doi: 10.1038/s41598-024-57295-5. Sci Rep. 2024. PMID: 38609396 Free PMC article.
Exploring cellular immunotherapy platforms in multiple myeloma.
Vo MC, Jung SH, Nguyen VT, Tran VD, Ruzimurodov N, Kim SK, Nguyen XH, Kim M, Song GY, Ahn SY, Ahn JS, Yang DH, Kim HJ, Lee JJ. Vo MC, et al. Among authors: lee jj. Heliyon. 2024 Mar 13;10(6):e27892. doi: 10.1016/j.heliyon.2024.e27892. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38524535 Free PMC article. Review.
Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913).
Shin HJ, Kim DY, Kim K, Min CK, Lee JJ, Mun YC, Lee WS, Lim SN, Kim JS, Moo JH, Kim DJ, Bang SM, Won JH, Jo JC, Koh YI. Shin HJ, et al. Among authors: lee jj. Cancer Res Treat. 2024 Mar 4. doi: 10.4143/crt.2024.074. Online ahead of print. Cancer Res Treat. 2024. PMID: 38453275 Free article.
Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202).
Cho H, Kim K, Yoon SE, Jung SH, Lee JJ, Moon JH, Cho HJ, Lee HS, Kang KW, Kim SY, Eom HS, Mun YC, Park YH, Yoon SS, Do YR, Lee WS, Min CK, Yoon DH. Cho H, et al. Among authors: lee jj. Hemasphere. 2024 Jan 26;8(1):e33. doi: 10.1002/hem3.33. eCollection 2024 Jan. Hemasphere. 2024. PMID: 38434530 Free PMC article. No abstract available.
Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study.
Ninkovic S, Harrison SJ, Lee JJ, Murphy N, Lee JH, Estell J, Chen VM, Horvath N, Kim K, Eek R, Augustson B, Bang SM, Huang SY, Rajagopal R, Szabo F, Engeler D, Butcher BE, Mollee P, Durie B, Chng WJ, Quach H. Ninkovic S, et al. Among authors: lee jj. Haematologica. 2024 Jan 18. doi: 10.3324/haematol.2023.284238. Online ahead of print. Haematologica. 2024. PMID: 38235519 Free article.
326 results